James H. Welch

2013 - AcelRx Pharmaceuticals

In 2013, James H. Welch earned a total compensation of $963.1K as Former Chief Financial Officer at AcelRx Pharmaceuticals, a 68% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$124,845
Option Awards$523,150
Salary$307,500
Other$7,650
Total$963,145

Welch received $523.2K in option awards, accounting for 54% of the total pay in 2013.

Welch also received $124.8K in non-equity incentive plan, $307.5K in salary and $7.7K in other compensation.

Rankings

In 2013, James H. Welch's compensation ranked 6,800th out of 12,286 executives tracked by ExecPay. In other words, Welch earned more than 44.7% of executives.

ClassificationRankingPercentile
All
6,800
out of 12,286
45th
Division
Manufacturing
2,404
out of 4,612
48th
Major group
Chemicals And Allied Products
726
out of 1,466
51st
Industry group
Drugs
534
out of 1,160
54th
Industry
Pharmaceutical Preparations
424
out of 890
52nd
Source: SEC filing on April 30, 2015.

Welch's colleagues

We found five more compensation records of executives who worked with James H. Welch at AcelRx Pharmaceuticals in 2013.

2013

Richard King

AcelRx Pharmaceuticals

Chief Executive Officer

2013

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2013

David Chung

AcelRx Pharmaceuticals

Chief Commercial Officer

2013

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

2013

Lawrence Hamel

AcelRx Pharmaceuticals

Chief Development Officer

In-depth

You may also like